Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

Trump says agreements with major drugmakers will cut prescription prices and boost U.S. investment, but economists caution ...

Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...

Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M - SiliconANGLE ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Millions of osteoporosis patients worldwide are set to benefit from a major international breakthrough, which will transform ...

Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the disease and yet another regulatory setback in another.